# Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial

> **NCT00476619** · PHASE4 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 17 (actual)

## Conditions studied

- Contrast Induced Nephropathy

## Interventions

- **DRUG:** erythropoeitin

## Key facts

- **NCT ID:** NCT00476619
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-09
- **Primary completion:** 2007-11
- **Final completion:** 2008-06
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** The exclusion criteria were stringent and enrollment was slow.
- **Last updated:** 2009-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00476619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00476619, "Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00476619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*